Trial Identifier: | D6830C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05110976 |
Start Date: | December 2021 |
Primary Completion Date: | August 2023 |
Study Completion Date: | August 2023 |
Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version |
Country | Location |
---|---|
DE | Berlin, DE, 10119 |
DE | Frankfurt, DE, 60596 |
DE | Großhansdorf, DE, 22927 |
DE | Lübeck, DE, 23552 |
DE | Magdeburg, DE, 39120 |
DE | Wiesbaden, DE, 65187 |
GB | Bradford, GB, BD9 6RJ |
GB | Cambridge, GB, CB2 0QQ |
GB | London, GB, HA1 3UJ |
GB | London, GB, W1T 6AH |
GB | London, GB, W12 0HS |
GB | Manchester, GB, M23 9QZ |
GB | NOTTINGHAM, GB, NG5 1PB |
GB | Portsmouth, GB, PO6 3LY |
HU | Budapest, HU, 1033 |
US, AZ | Tempe, AZ, US, 85283 |
US, CA | Bakersfield, CA, US, 93301 |
US, CA | Glendale, CA, US, 91206 |
US, CA | San Jose, CA, US, 95117 |
US, CO | Denver, CO, US, 80230 |
US, FL | Hialeah, FL, US, 33012 |
US, FL | Homestead, FL, US, 33030 |
US, FL | Miami, FL, US, 33173 |
US, FL | Miami, FL, US, 33155 |
US, FL | Miami, FL, US, 33122 |
US, FL | Miami, FL, US, 33144 |
US, FL | Miami, FL, US, 33175 |
US, ID | Boise, ID, US, 83706 |
US, MA | North Dartmouth, MA, US, 02747 |
US, MD | White Marsh, MD, US, 21162 |
US, MI | Ann Arbor, MI, US, 48105 |
US, MO | Kansas City, MO, US, 64114 |
US, MO | Saint Louis, MO, US, 63141 |
US, NC | Raleigh, NC, US, 27607 |
US, NJ | New Brunswick, NJ, US, 08901 |
US, NY | New York, NY, US, 10032 |
US, OH | Toledo, OH, US, 43617 |
US, OR | Portland, OR, US, 97202 |
US, TX | El Paso, TX, US, 79903 |